MABPAIR

Pharmaceutical compounds and compositions for the treatment of cancer, autoimmune diseases, metabolic disorders, hematological and neurological diseases; therapeutic agents for cancer, autoimmune diseases, metabolic disorders, hematological and neurological diseases; pharmaceutical preparations, namely, immunotherapy agents in the nature of monoclonal antibodies, medical diagnostic buffers, and reagents for use in cancer, autoimmune diseases, metabolic disorders, hematological and neurological diseases disease testing and treatment for medical purposes; all of the foregoing containing monoclonal antibodies

Pharmaceutical research and drug development; research and development related to drugs for immunotherapies; research and development services in the field of monoclonal antibodies; Providing access to a technology platform for developing custom-designed antibody combinations